Alzheimer’s Disease International (ADI) has applied to have anti-dementia medications placed on the World Health Organisation’s Essential Medicines List. ADI said that the move, made alongside Newcastle University and the LSE, would ensure everyone everywhere had equitable and affordable access to dementia medications.
